Concepedia

Min Du

MD

Statistics

Publications

22

Citations

2K

H-Index

19

Active since

1997

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Peking University Shenzhen Hospital

Chengdu Military General Hospital

Qilu Hospital of Shandong University

University of Michigan

Min Du is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and oncology.

ORCID

Publications per year

1997–2024

22

Publications

22

Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism

Hélène Pelicano, Rui‐Hua Xu, Min Du et al. · The Journal of Cell Biology · 2006 · 391 citations · Full text

, , +17

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

Hagop M. Kantarjian, Varsha Gandhi, Jörge E. Cortes et al. · Blood · 2003 · 313 citations · Full text

, , +12

Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias

Stefan Faderl, Varsha Gandhi, Susan O’Brien et al. · Blood · 2004 · 211 citations

, , +10

Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism

Dunyaporn Trachootham, Hui Zhang, Wan Zhang et al. · Blood · 2008 · 201 citations · Full text

, , +13

Phase I Clinical and Pharmacology Study of Clofarabine in Patients With Solid and Hematologic Cancers

Hagop M. Kantarjian, Varsha Gandhi, Peter Kozuch et al. · Journal of Clinical Oncology · 2003 · 191 citations

, , +15

1–5 of 22